Shares of Xometry fell sharply in morning trading today, dropping -13.0% after the AI-native manufacturing marketplace disclosed the pricing of an underwritten public offering of Class A common stock totaling $225 million. The offering was set at $85.00 per share - a marked discount to recent trading levels - and comprised roughly 2.65 million newly issued shares.
Under the terms announced, underwriters received a 30-day option to purchase up to an additional 397,058 shares at the identical offering price. Xometry said the transaction is expected to close on June 3, 2026. The company indicated it will apply the net proceeds toward working capital and general corporate purposes and did not identify any specific acquisition or capital projects to be funded by the placement.
Investor reaction was amplified by the timing of regulatory filings. On June 1, the same day the company submitted its shelf registration, a Form 144 was filed, a notice that typically signals a planned sale of restricted or control securities by an insider or an affiliate. That filing, closely preceding the priced offering, heightened market concern about near-term dilution and contributed to the selling pressure.
Several major investment banks are handling the transaction. J.P. Morgan and Goldman Sachs were named as joint book-running managers. Additional participants in the underwriting syndicate include William Blair, Citizens Capital Markets, Cantor, and Craig-Hallum.
Market context did little to explain the decline in Xometry's share price. The S&P 500 was essentially flat and the NASDAQ showed a slight gain on the day, indicating the move in Xometry was driven by company-specific actions rather than broad market or sector weakness. The offering announcement arrived at a sensitive moment for the stock, which had been trading near its 52-week high of $99.86 prior to the news.
In summary, the combination of a sizeable equity raise that will increase share count, an offering priced below recent trading levels, rapid shelf-registration mechanics and a concurrent Form 144 filing created a confluence of negative signals for investors. Those factors together erased a substantial portion of the gains Xometry had accumulated over recent months, notwithstanding the companys strong business momentum referenced in prior trading.
Summary
Xometry priced a $225 million underwritten offering at $85.00 per share, selling approximately 2.65 million new Class A shares and granting underwriters a 30-day option on an additional 397,058 shares. A Form 144 filed on the same day as the shelf registration signaled potential insider sales. The deal is expected to close on June 3, 2026, and proceeds are earmarked for working capital and general corporate purposes. J.P. Morgan and Goldman Sachs lead the transaction, with several other firms participating. The stock fell -13.0% in morning trading, while broader indexes were largely unchanged.
Key points
- The offering is priced at $85.00 per share for approximately 2.65 million new Class A shares, with a 30-day option for up to 397,058 additional shares.
- A Form 144 filing was made on June 1, timed the same day as the shelf registration, signaling potential insider or affiliate sales and increasing dilution concerns.
- Market reaction was company-specific: the S&P 500 was flat and the NASDAQ was marginally higher, indicating no broader market catalyst for the decline.
Risks and uncertainties
- Share dilution from the newly issued stock and any exercised underwriter option could reduce existing shareholders ownership percentage - a concern for equity investors and the broader equity market segment focused on technology-enabled manufacturing platforms.
- Near-term selling pressure could be intensified if shares referenced in the Form 144 are marketed, introducing additional supply into the market and increasing price volatility in the stock.
- The timing of the shelf registration and the rapid succession of filings left limited clarity on the ultimate use of proceeds beyond general working capital, presenting execution and governance uncertainty for investors.